
Covid
BioNTech expects COVID-19 vaccine sales to fall
German vaccine maker BioNTech has said it expects sales of its COVID-19 vaccine to fall to around 5 billion euros (5.4 billion U.S. dollars) in 2023, the company said Monday. In 2022, BioNTech recorded sales [Read More]